Cho DY - Search Results

1

Evaluations and Mechanistic Interrogation of Natural Products Isolated From Paeonia suffruticosa for the Treatment of Inflammatory Bowel Disease.

Wu KC, Lee DY, Hsu JT, Cheng CF, Lan JL, Chiu SC, Cho DY, Hsu JL. Wu KC, et al. Among authors: cho dy. Front Pharmacol. 2021 Dec 6;12:696158. doi: 10.3389/fphar.2021.696158. eCollection 2021. Front Pharmacol. 2021. PMID: 34938175 Free PMC article.

2

The role of cancer stem cells (CD133(+)) in malignant gliomas.

Cho DY, Lin SZ, Yang WK, Hsu DM, Lin HL, Lee HC, Lee WY, Chiu SC. Cho DY, et al. Cell Transplant. 2011;20(1):121-5. doi: 10.3727/096368910X532774. Epub 2010 Sep 30. Cell Transplant. 2011. PMID: 20887676 Free article.

3

Therapeutic potential of microRNA let-7: tumor suppression or impeding normal stemness.

Chiu SC, Chung HY, Cho DY, Chan TM, Liu MC, Huang HM, Li TY, Lin JY, Chou PC, Fu RH, Yang WK, Harn HJ, Lin SZ. Chiu SC, et al. Among authors: cho dy. Cell Transplant. 2014;23(4-5):459-69. doi: 10.3727/096368914X678418. Cell Transplant. 2014. PMID: 24816444 Free article. Review.

4

Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.

Jan CI, Tsai WC, Harn HJ, Shyu WC, Liu MC, Lu HM, Chiu SC, Cho DY. Jan CI, et al. Among authors: cho dy. Front Immunol. 2018 May 29;9:727. doi: 10.3389/fimmu.2018.00727. eCollection 2018. Front Immunol. 2018. PMID: 29910795 Free PMC article. Clinical Trial.

5

Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages.

Chuang HY, Su YK, Liu HW, Chen CH, Chiu SC, Cho DY, Lin SZ, Chen YS, Lin CM. Chuang HY, et al. Among authors: cho dy. J Clin Med. 2019 Jul 2;8(7):959. doi: 10.3390/jcm8070959. J Clin Med. 2019. PMID: 31269723 Free PMC article.

6

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment.

Hsiao CH, Chiu YH, Chiu SC, Cho DY, Lee LM, Wen YC, Li JJ, Shih PH. Hsiao CH, et al. Among authors: cho dy. J Vis Exp. 2020 Jan 24;(155). doi: 10.3791/60420. J Vis Exp. 2020. PMID: 32065149

7

Cytokine-induced Killer T Cells Enhance the Cytotoxicity Against Carboplatin-resistant Ovarian Cancer Cells.

Pan Y, Chiu YH, Chiu SC, Cho DY, Lee LM, Wen YC, Whang-Peng J, Hsiao CH, Shih PH. Pan Y, et al. Among authors: cho dy. Anticancer Res. 2020 Jul;40(7):3865-3872. doi: 10.21873/anticanres.14376. Anticancer Res. 2020. PMID: 32620626

8

MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme.

Pan CM, Chan KH, Chen CH, Jan CI, Liu MC, Lin CM, Cho DY, Tsai WC, Chu YT, Cheng CH, Chuang HY, Chiu SC. Pan CM, et al. Among authors: cho dy. Cancer Lett. 2020 Nov 28;493:133-142. doi: 10.1016/j.canlet.2020.08.024. Epub 2020 Aug 27. Cancer Lett. 2020. PMID: 32861705 Free article.

9

Gamma/Delta T-Cells Enhance Carboplatin-induced Cytotoxicity Towards Advanced Bladder Cancer Cells.

Pan Y, Chiu YH, Chiu SC, Cho DY, Lee LM, Wen YC, Whang-Peng J, Hsiao CH, Shih PH. Pan Y, et al. Among authors: cho dy. Anticancer Res. 2020 Sep;40(9):5221-5227. doi: 10.21873/anticanres.14525. Anticancer Res. 2020. PMID: 32878810

10

A systematic identification of anti-inflammatory active components derived from Mu Dan Pi and their applications in inflammatory bowel disease.

Chen TF, Hsu JT, Wu KC, Hsiao CF, Lin JA, Cheng YH, Liu YH, Lee DY, Chang HH, Cho DY, Hsu JL. Chen TF, et al. Among authors: cho dy. Sci Rep. 2020 Oct 14;10(1):17238. doi: 10.1038/s41598-020-74201-x. Sci Rep. 2020. PMID: 33057107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

722 results

Search Page

Filters